UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000005228
Receipt No. R000006187
Scientific Title Phase II study of bevacizumab and irinotecan as second-line therapy in patients with metastatic colorectal cancer previously treated with fluoropyrimidine, oxaliplatin, and bevacizumab
Date of disclosure of the study information 2011/03/09
Last modified on 2016/03/09 11:19:56

No. Disposal Last modified on Item of update
1 Insert 2011/03/09 23:04:39
2 Update 2011/03/14 12:12:52 Recruitment status
Date of protocol fixation
Anticipated trial start date
3 Update 2013/03/09 10:55:59 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2014/09/19 06:21:43 TEL
Email
Address
Address
TEL
5 Update 2014/09/19 06:22:54 Recruitment status
6 Update 2016/03/09 11:19:56 Recruitment status
Date trial data considered complete
Date analysis concluded


Contact us.